<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Murthy D</submitter><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>613-627</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11021164</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>26(4)</volume><pubmed_abstract>The ability of tumour cells to thrive in harsh microenvironments depends on the utilization of nutrients available in the milieu. Here we show that pancreatic cancer-associated fibroblasts (CAFs) regulate tumour cell metabolism through the secretion of acetate, which can be blocked by silencing ATP citrate lyase (ACLY) in CAFs. We further show that acetyl-CoA synthetase short-chain family member 2 (ACSS2) channels the exogenous acetate to regulate the dynamic cancer epigenome and transcriptome, thereby facilitating cancer cell survival in an acidic microenvironment. Comparative H3K27ac ChIP-seq and RNA-seq analyses revealed alterations in polyamine homeostasis through regulation of SAT1 gene expression and enrichment of the SP1-responsive signature. We identified acetate/ACSS2-mediated ace</pubmed_abstract><journal>Nature cell biology</journal><pubmed_title>Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis.</pubmed_title><pmcid>PMC11021164</pmcid><funding_grant_id>P30 CA036727</funding_grant_id><funding_grant_id>U54CA274329</funding_grant_id><funding_grant_id>P20 GM113126</funding_grant_id><funding_grant_id>P50 CA127297</funding_grant_id><funding_grant_id>P30 GM103335</funding_grant_id><funding_grant_id>R01CA270234</funding_grant_id><funding_grant_id>P20 GM121316</funding_grant_id><funding_grant_id>R01 CA270234</funding_grant_id><funding_grant_id>R01CA256911</funding_grant_id><funding_grant_id>T32 CA009476</funding_grant_id><funding_grant_id>R01 CA256911</funding_grant_id><funding_grant_id>R01CA163649</funding_grant_id><funding_grant_id>R01 CA163649</funding_grant_id><funding_grant_id>R37 CA276924</funding_grant_id><funding_grant_id>R37CA276924</funding_grant_id><funding_grant_id>P20 GM103447</funding_grant_id><funding_grant_id>U54 CA274329</funding_grant_id><funding_grant_id>P30 CA225520</funding_grant_id><funding_grant_id>R50 CA211462</funding_grant_id><pubmed_authors>Rai V</pubmed_authors><pubmed_authors>Rana S</pubmed_authors><pubmed_authors>Kumar V</pubmed_authors><pubmed_authors>Hu T</pubmed_authors><pubmed_authors>Chaudhary S</pubmed_authors><pubmed_authors>Wellen KE</pubmed_authors><pubmed_authors>Thakur R</pubmed_authors><pubmed_authors>Wang D</pubmed_authors><pubmed_authors>Yu F</pubmed_authors><pubmed_authors>Klinkebiel DL</pubmed_authors><pubmed_authors>Souchek J</pubmed_authors><pubmed_authors>Black AR</pubmed_authors><pubmed_authors>Pacheco C</pubmed_authors><pubmed_authors>Natarajan A</pubmed_authors><pubmed_authors>Jain A</pubmed_authors><pubmed_authors>Lazenby AJ</pubmed_authors><pubmed_authors>Mehla K</pubmed_authors><pubmed_authors>Patel R</pubmed_authors><pubmed_authors>Chaika NV</pubmed_authors><pubmed_authors>Hollingsworth MA</pubmed_authors><pubmed_authors>Dasgupta A</pubmed_authors><pubmed_authors>Kollala SS</pubmed_authors><pubmed_authors>King RJ</pubmed_authors><pubmed_authors>Shukla SK</pubmed_authors><pubmed_authors>He C</pubmed_authors><pubmed_authors>Grandgenett PM</pubmed_authors><pubmed_authors>Singh PK</pubmed_authors><pubmed_authors>Powers R</pubmed_authors><pubmed_authors>Jha K</pubmed_authors><pubmed_authors>Mulder SE</pubmed_authors><pubmed_authors>Edil BH</pubmed_authors><pubmed_authors>Murthy D</pubmed_authors><pubmed_authors>Hwang RF</pubmed_authors><pubmed_authors>Attri KS</pubmed_authors><pubmed_authors>Gebregiworgis T</pubmed_authors><pubmed_authors>Ulhannan S</pubmed_authors><pubmed_authors>Ly Q</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis.</name><description>The ability of tumour cells to thrive in harsh microenvironments depends on the utilization of nutrients available in the milieu. Here we show that pancreatic cancer-associated fibroblasts (CAFs) regulate tumour cell metabolism through the secretion of acetate, which can be blocked by silencing ATP citrate lyase (ACLY) in CAFs. We further show that acetyl-CoA synthetase short-chain family member 2 (ACSS2) channels the exogenous acetate to regulate the dynamic cancer epigenome and transcriptome, thereby facilitating cancer cell survival in an acidic microenvironment. Comparative H3K27ac ChIP-seq and RNA-seq analyses revealed alterations in polyamine homeostasis through regulation of SAT1 gene expression and enrichment of the SP1-responsive signature. We identified acetate/ACSS2-mediated ace</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Apr</publication><modification>2026-05-29T17:47:28.142Z</modification><creation>2026-04-08T05:45:23.258Z</creation></dates><accession>S-EPMC11021164</accession><cross_references><pubmed>38429478</pubmed><doi>10.1038/s41556-024-01372-4</doi></cross_references></HashMap>